✦ LIBER ✦

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

✍ Scribed by Pirow J Bekker; Donna L Holloway; Amy S Rasmussen; Robyn Murphy; Steven W Martin; Philip T Leese; Gregory B Holmes; Colin R Dunstan; Alex M DePaoli

Book ID: 111485071
Publisher: American Society for Bone and Mineral Research
Year: 2004
Tongue: English
Weight: 99 KB
Volume: 19
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.040305

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-dose, placebo-controlled, randomi

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

✍ Desmond Padhi; Graham Jang; Brian Stouch; Liang Fang; Edward Posvar 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 248 KB

Sclerostin, an osteocyte-secreted protein, negatively regulates osteoblasts and inhibits bone formation. In this first-in-human study, a sclerostin monoclonal antibody (AMG 785) was administered to healthy men and postmenopausal women. In this phase I, randomized, double-blind, placebo-controlled, a

EFFECTS OF AMG 145, A FULLY HUMAN MONOCL

EFFECTS OF AMG 145, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST PCSK9, ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN SUBJECTS TAKING STATINS: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ASCENDING MULTIPLE-DOSE STUDY

✍ Dias, Clapton; Shaywitz, Adam; Cooke, Blaire; Uy, Stephen; Emery, Maurice; Gibbs 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 92 KB

T1145 A Double-Blind, Placebo-Controlled

T1145 A Double-Blind, Placebo-Controlled, Dose-Escalation, Safety and Pharmacokinetic Study of MDX-1100, a Fully Human Anti-CXCL10 Monoclonal Antibody, in Healthy Subjects

✍ Yellin, Michael; Goldwater, Ronald; Blanset, Diann L.; Cardarelli, Pina M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A randomized, double-blind study of AMG

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee

✍ Stanley B Cohen, Susanna Proudman, Alan J Kivitz… 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

A phase 2 randomized, double-blind study

A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis

✍ Mario H Cardiel, Paul P Tak, William Bensen… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 471 KB

Phase I, double-blind, randomized, place

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease

✍ C. Janneke van der Woude; Pieter Stokkers; Ad A. van Bodegraven; Gert Van Assche 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

Background: NI-0401 is a fully human monoclonal antibody, which binds to the CD3 subunit of the T-cell receptor, causing modulation of T-cell activity. We investigated the safety and the ability to modulate the TCR-CD3 complex of NI-0401 in patients with active Crohn's disease (CD). Methods: A doub